A valid prescription requires a telehealth consultation with a licensed provider. No medication is dispensed without clinical evaluation.
Semax / Selank (Nasal)
Neurological & Neuropeptide Nasal Spray Formulations
Compound Specifications
Semax / Selank (Nasal)
Neurological & Neuropeptide Nasal Spray Formulations
A dual-peptide intranasal research formulation combining Semax (a synthetic ACTH-analog peptide studied for its neuro-active pathways and BDNF expression in laboratory models) with Selank (a synthetic tuftsin analog investigated for its potential modulation of GABAergic and stress signaling pathways).
Preclinical studies indicate Semax may interact with monoaminergic systems and brain-derived neurotrophic factor (BDNF), while Selank has been studied for potential interactions with GABAergic signaling involved in stress response.
Documented Therapeutic Benefits
Results may vary. Individual outcomes depend on adherence, baseline health, and other factors.
1-2 sprays per nostril, 2-3 times daily or as clinically directed.
Frequently Asked Clinical Questions
Why a nasal spray instead of an injection?
Intranasal administration has been studied for direct access across olfactory and mucosal pathways to support central nervous system delivery without injection.
Will the Selank component cause sedation?
Preclinical literature describes Selank as interacting with GABAergic regulatory systems without typical hypnotic sedation.